ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.218,30
-0,11%
S&P 500
5.996,66
1,00%
US Dollar vs BRL
6,077
-0,06%
Bitcoin
106.902,97
3,68%
Brent Oil
80,075
-0,17%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Agilent Technologies (A)

  7. Agilent Technologies (A) Notícias

A

Agilent Technologies (A)

Agilent Technologies
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:A
DataHoraFonteTítuloCódigoCompanhia
14/01/202511:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:AAgilent Technologies
13/01/202510:00Business WireAgilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London ScientistsNYSE:AAgilent Technologies
19/12/202415:45Business WireAgilent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:AAgilent Technologies
13/12/202411:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:AAgilent Technologies
10/12/202413:09Business WireAgilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR CertificationNYSE:AAgilent Technologies
03/12/202420:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AAgilent Technologies
26/11/202412:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:AAgilent Technologies
25/11/202418:05Business WireAgilent Reports Fourth-Quarter Fiscal Year 2024 Financial ResultsNYSE:AAgilent Technologies
25/11/202411:01Business WireAgilent Announces New Organizational Structure to Support its Market-Focused StrategyNYSE:AAgilent Technologies
20/11/202418:05Business WireAgilent Increases Cash Dividend to 24.8 Cents per ShareNYSE:AAgilent Technologies
20/11/202410:00Business WireAgilent 2024 Early Career Professor Award Presented to Adeyemi AdeleyeNYSE:AAgilent Technologies
19/11/202418:29Business WireAgilent Ranks No. 11 on Fortune’s List of Best Workplaces in the WorldNYSE:AAgilent Technologies
14/11/202410:00Business WireAgilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial ResearchNYSE:AAgilent Technologies
06/11/202410:00Business WireAgilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California ScientistsNYSE:AAgilent Technologies
21/10/202403:00Business WireAgilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC SeriesNYSE:AAgilent Technologies
16/10/202417:30Business WireAgilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25NYSE:AAgilent Technologies
30/09/202418:17Business WireAgilent to Host Analyst and Investor Day on Dec. 17, 2024NYSE:AAgilent Technologies
27/09/202413:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AAgilent Technologies
20/09/202412:01Business WireAgilent Completes Acquisition of BIOVECTRANYSE:AAgilent Technologies
18/09/202417:20Business WireAgilent Announces Cash Dividend of 23.6 Cents per ShareNYSE:AAgilent Technologies
09/09/202409:00Business WireAgilent Unveils Biopharma CDx Services Lab to Accelerate Precision MedicineNYSE:AAgilent Technologies
04/09/202419:18Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:AAgilent Technologies
04/09/202409:25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:AAgilent Technologies
03/09/202410:12Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:AAgilent Technologies
22/08/202406:37IH Market NewsSchwab and Snowflake Retreat in Premarket, WeRide Postpones IPO, Halliburton Cyberattack, McDonald’s Instagram HackNYSE:AAgilent Technologies
21/08/202417:05Business WireAgilent Reports Third-Quarter Fiscal Year 2024 Financial ResultsNYSE:AAgilent Technologies
15/08/202409:00Business WireAgilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph PerformanceNYSE:AAgilent Technologies
02/08/202409:00Business WireAgilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell TherapyNYSE:AAgilent Technologies
29/07/202410:55Business WireAgilent Acquires Sigsense, Creator of AI-Enabled Lab Operations TechnologyNYSE:AAgilent Technologies
23/07/202407:00IH Market NewsJohnson Controls Division Sold for $8 Billion; Alphabet’s Offer Rejected by Wiz; AMD President Announces RetirementNYSE:AAgilent Technologies
 Apresentando as notícias mais relevantes sobre:NYSE:A

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
AZEV4
AZEVEDO PN
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
TECN3
TECHNOS ON
BOV
GOLL4
GOL PN
BOV
RAIZ4
Raizen S.A PN
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados